Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 29, Issue 6, Pages 1258-1261Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.29.1258
Keywords
Punica granatuin; tumor necrosis factor (Tnf); nuclear factor kappa b (Nf kappa b); lipopolysaccharide (LPS); BV2 microglial cell
Categories
Ask authors/readers for more resources
While the anti-oxidant properties of Punica granatum methanol extract (PGMF) are well documented, little is known concerning the anti-inflammatory effect of Punica granatum. PGMF was pretreated in BV2 microglial cells and cells were stimulated to induce inflammation by lipopolysaccharide (LPS). The effect of PGME on the production and expression of tumor necrosis factor alpha (Tnf, previously known as Tnf alpha) was determined by enzyme-linked immunosorbent assay (ELISA), western blotting, and reverse transcription-polymerase chain reaction (RT-PCR). In addition, the expression of nuclear factor kappa b (Nf kappa b) was measured using an electrophoretic mobility shift assay (EMSA). By ELISA, PGME at the concentrations of 1, 5, 10, and 50 mu g/ml inhibited Tnf production in LPS-stimulated cells by 30.2, 42.3, 57.6, and 88.4%, respectively, compared to LPS-stimulated cells. The LPS-stimulated Tnf production was reduced with a dose-dependent manner. Immuno blot and RT-PCR analyses revealed that PGME of 5 and 50 mu g/ml inhibited the expression of both protein and mRNA levels of Tnf compared to LPS-stimulated cells. EMSA revealed that PGME of 5 and 50 mu g/ml blocked the LPSstimulated activation of Nf kappa b. These data suggest that PGME may suppress LPS-stimulated Tnf production through inhibition of Nf kappa b in BV2 microglia cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available